Key result
Recombinant ACE2 protein remarkably reversed SARS-CoV-2 spike RBD protein-aggravated LPS-induced acute lung injury in mice by directly binding the spike RBD protein and modulating the ACE2-AngII-AT1R-NOX1/2 axis.
Why the study?
Whether recombinant ACE2 protein protects against SARS-CoV-2-induced acute lung injury in animal models and its underlying mechanisms remained unelucidated.
Does recombinant ACE2 protein prevent SARS-CoV-2 spike RBD protein-aggravated LPS-induced acute lung injury in mice?
Does recombinant ACE2 protein prevent SARS-CoV-2 spike RBD protein-aggravated LPS-induced acute lung injury in mice?
Recombinant ACE2 protein protects against SARS-CoV-2 spike RBD protein-aggravated acute lung injury in mice by modulating the ACE2-AngII-AT1R-NOX1/2 axis.
Answers are grounded in this paper and cite their sources.
Animal data suggest rACE2 benefit in SARS-CoV-2 ALI; leaves open translation to human ARDS.
Background SARS-CoV-2 infection leads to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Both clinical data and animal experiments suggest that the renin–angiotensin system (RAS) is involved in the pathogenesis of SARS-CoV-2-induced ALI. Angiotensin-converting enzyme 2 (ACE2) is the functional receptor for SARS-CoV-2 and a crucial negative regulator of RAS. Recombinant ACE2 protein (rACE2) has been demonstrated to play protective role against SARS-CoV and avian influenza-induced ALI, and more relevant, rACE2 inhibits SARS-CoV-2 proliferation in vitro. However, whether rACE2 protects against SARS-CoV-2-induced ALI in animal models and the underlying mechanisms have yet to be elucidated. Methods and Results Here, we demonstrated that the SARS-CoV-2 spike receptor-binding domain (RBD) protein aggravated lipopolysaccharide (LPS)-induced ALI in mice. SARS-CoV-2 spike RBD protein directly binds and downregulated ACE2, leading to an elevation in angiotensin (Ang) II. AngII further increased the NOX1/2 through AT 1 R, subsequently causing oxidative stress and uncontrolled inflammation and eventually resulting in ALI/ARDS. Importantly, rACE2 remarkably reversed SARS-CoV-2 spike RBD protein-induced ALI by directly binding SARS-CoV-2 spike RBD protein, cleaving AngI or cleaving AngII. Conclusion This study is the first to prove that rACE2 plays a protective role against SARS-CoV-2 spike RBD protein-aggravated LPS-induced ALI in an animal model and illustrate the mechanism by which the ACE2-AngII-AT 1 R-NOX1/2 axis might contribute to SARS-CoV-2-induced ALI.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied Acute lung injury (ALI). Recombinant human ACE2 protein (rACE2) vs. Bovine serum albumin (BSA) was evaluated on Lung injury score and pulmonary edema. Recombinant ACE2 protein remarkably reversed SARS-CoV-2 spike RBD protein-aggravated LPS-induced acute lung injury in mice by directly binding the spike RBD protein and modulating the ACE2-AngII-AT1R-NOX1/2 axis.
Synapse has enriched 10 related papers. Consider them for comparative context: